Search for a command to run...
Jennifer Doudna, Nobel Prize-winning biochemist, discusses the present and future of CRISPR gene editing technologies, highlighting breakthrough therapies for sickle cell disease and rare genetic disorders, while exploring potential applications in agriculture, preventive medicine, and the intersection of CRISPR with AI.